<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83765">
  <stage>Registered</stage>
  <submitdate>29/03/2009</submitdate>
  <approvaldate>25/05/2009</approvaldate>
  <actrnumber>ACTRN12609000346279</actrnumber>
  <trial_identification>
    <studytitle>Ultrasound guided femoral catheter placement for analgesia after major knee surgery: A comparison of two approaches</studytitle>
    <scientifictitle>Optimising Analgesia after Knee Surgery: A comparison of two approaches for femoral nerve catheter placement</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>FNC09</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Pain relief after knee surgery</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>In-plane needle approach (needle in the plane of the ultrasound beam with ultrasound (US) probe just distal to inguinal crease and needle placed in-line with beam from lateral to medial) for placement of femoral nerve catheters for knee surgery
Approx 15 mins
Primary ropivacaine dose = 100mg
Infusion Ropivacaine = 0.2% at 2 ml/hr and as required 5 ml boluses</interventions>
    <comparator>Out-of-plane needle approach (needle perpendicular to the plane of the ultrasound beam with US probe just distal to inguinal crease and needle placed in a caudal to cephalad direction) for placement of femoral nerve catheters for knee surgery
Primary ropivacaine dose = 100mg
Infusion Ropivacaine = 0.2% at 2 ml/hr and as required 5 ml boluses</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Pain after knee surgery, assessed by analgesia requirements and numerical rating pain scores (NRPS) postoperatively</outcome>
      <timepoint>From time of surgery until Day 2 postoperatively.  NRPS and analgesic consumption measured once each on the afternoon of Day 1 and Day 2 following surgery.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Needle manipulation as measure by needle time under the skin recorded by the investigators</outcome>
      <timepoint>At the time of needle insertion until exiting the skin over the catheter</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients requiring analgesia for knee surgery under the care of the principal investigator</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Patient refusal of femoral nerve block.  2. Known neuropathy involving the leg undergoing surgery.  3. Known allergy to amide local anaesthetic drugs.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Initial invitation to participate in the study will occur in the surgeon's rooms.  Approximately one week prior to surgery, patients will be contacted by a research assistant to provide further informed consent.  Written informed consent will be obtained from all patients.  Assignment of the patient to in-plane or out-of-plane needle approach will be delivered in a sealed opaque envelope.</concealment>
    <sequence>A computerised random number generator will be used to assign the patient to one of the 2 groups.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/04/2009</anticipatedstartdate>
    <actualstartdate>14/04/2009</actualstartdate>
    <anticipatedenddate />
    <actualenddate>23/07/2012</actualenddate>
    <samplesize>80</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Michael Fredrickson</primarysponsorname>
    <primarysponsoraddress>Anaesthesia Institute
P O Box 109 199
Newmarket
Auckland 1149</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>I-Flow Corporation</fundingname>
      <fundingaddress>20202 Windrow Drive Lake Forest CA 92630</fundingaddress>
      <fundingcountry>United States of America</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>If the primary hypothesis is confirmed, this study will provide evidence supporting the 'in-plane' needle approach for femoral catheter placement.  Increased exposure of the techniques may promote their uptake in this setting.</summary>
    <trialwebsite />
    <publication>Fredrickson, MJ: Danesh-Clough T K. (Sep 2009) Ambulatory continuous femoral analgesia for major knee surgery: a randomised study of ultrasound-guided femoral catheter placement.  Anaesthesia and Intensive Care. Vol: 37(5). pp 758-66</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Northern Y Regional Ethics Committee</ethicname>
      <ethicaddress>P O Box 1031
Hamilton
Waikato Mail Centre 3240</ethicaddress>
      <ethicapprovaldate>31/03/2009</ethicapprovaldate>
      <hrec>NTY/09/19/EXP</hrec>
      <ethicsubmitdate>9/03/2009</ethicsubmitdate>
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Dr Michael Fredrickson</name>
      <address>Anaesthesia Institute
P O Box 109 199
Newmarket
Auckland 1149</address>
      <phone>+64 9 522 1117</phone>
      <fax>+64 9 522 1127</fax>
      <email>anaesthesiainstitute@yahoo.com</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Dr Michael Fredrickson</name>
      <address>Anaesthesia Institute
P O Box 109 199
Newmarket
Auckland 1149</address>
      <phone>+64 9 522 1117</phone>
      <fax>+64 9 522 1127</fax>
      <email>anaesthesiainstitute@yahoo.com</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Mrs</title>
      <name>Linda White</name>
      <address>Anaesthesia Institute
P O Box 109 199
Newmarket
Auckland 1149</address>
      <phone>+64 9 522 1117</phone>
      <fax>+64 9 522 1127</fax>
      <email>anaesthesiainstitute@yahoo.com</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Michael Fredrickson</name>
      <address>Anaesthesia Institute
P O Box 109199
Newmarket
Auckland 1149</address>
      <phone>+6495221117</phone>
      <fax />
      <email>anaesthesiainstitute@yahoo.com</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>